MedTrace Logo

Early and Late Prognosis in Patients With Guillain-Barre Syndrome

NCT06041451 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2023-09-18

No results posted yet for this study

Summary

The goal of this observational study is to explore significant indicators to predict the early prognosis and late prognosis in patients with Guillain-Barre syndrome.

Conditions

  • Guillain-Barre Syndrome

Interventions

DRUG

Intravenous Immunoglobulins, Human

patients were treated with intravenous immunoglobulin(30g ivgtt qd) for 5 days

DRUG

Methylprednisolone 500 MG Injection

patients were treated with methylprednisolone

Sponsors & Collaborators

  • First Affiliated Hospital of Wenzhou Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-02
Primary Completion
2022-12-01
Completion
2025-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06041451 on ClinicalTrials.gov